Calvin Sternick

Stock Analyst at JP Morgan

(2.01)
# 3,062
Out of 5,112 analysts
19
Total ratings
46.15%
Success rate
6.82%
Average return

Stocks Rated by Calvin Sternick

U.S. Physical Therapy
Mar 19, 2025
Maintains: Overweight
Price Target: $120$110
Current: $78.72
Upside: +39.74%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85$80
Current: $38.87
Upside: +105.81%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $34.68
Upside: -22.15%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144$182
Current: $224.90
Upside: -19.08%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91$81
Current: $195.02
Upside: -58.47%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367$392
Current: $162.30
Upside: +141.53%